Livleen Veslemes Named ‘Change Maker’ of the Year by BCBusiness

NEXT STORY
electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in the U.K.
PREV STORY
CAHI Statement on Implementation of Additional Government Measures in Response to COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company

-Merger would create publicly-traded immuno-oncology biotechnology company developing novel products for treating early- and ...

author_avatar
NASDAQ Market News

Basilea berichtet positive Interim-Ergebnisse für Phase-2-Studie FIDES-01 mit Derazantinib bei Patienten mit Gallengangkrebs (iCCA) mit Mutationen oder Amplifikationen des FGFR2-Gens

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech Oy converts Convertible Capital Notes into shares and exceeds the authorization granted in the Extraordinary General Meeting on February 6, 2018

FIT Biotech Oy Company release March 21, 2018 at 03:30 PM EET FIT Biotech ...

author_avatar
NASDAQ Market News